{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:47:09Z","timestamp":1794268029697,"version":"4.9.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008173","name":"Intermountain Research and Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.chest.2020.08.2069","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T16:28:55Z","timestamp":1598977735000},"page":"337-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":333,"title":["Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"159","author":[{"given":"Raymond L.","family":"Benza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manreet K.","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amresh","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline V.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Selej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Greg","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chest.2020.08.2069_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.chest.2020.08.2069_bib2","doi-asserted-by":"crossref","first-page":"1701353","DOI":"10.1183\/13993003.01353-2017","article-title":"Assessing risk in pulmonary arterial hypertension: what we know, what we don\u2019t","volume":"50","author":"Benza","year":"2017","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.chest.2020.08.2069_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1164\/rccm.201801-0042ED","article-title":"Risk assessment tools in pulmonary arterial hypertension. Prognosis for prospective trials?","volume":"197","author":"Farber","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2020.08.2069_bib4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1164\/rccm.201709-1840PP","article-title":"The low-risk profile in pulmonary arterial hypertension. Time for a paradigm shift to goal-oriented clinical trial endpoints?","volume":"197","author":"Weatherald","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2020.08.2069_bib5","doi-asserted-by":"crossref","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2020.08.2069_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1378\/chest.11-0676","article-title":"The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension","volume":"141","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2020.08.2069_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2020.08.2069_bib8","doi-asserted-by":"crossref","first-page":"1700740","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur Respir J"},{"issue":"47","key":"10.1016\/j.chest.2020.08.2069_bib9","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","article-title":"A\u00a0comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension","volume":"39","author":"Kylhammar","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.chest.2020.08.2069_bib10","doi-asserted-by":"crossref","first-page":"1700889","DOI":"10.1183\/13993003.00889-2017","article-title":"Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2020.08.2069_bib11","doi-asserted-by":"crossref","unstructured":"Dardi F, Palazzini M, Gotti E, et\u00a0al. Simplified table for risk stratification in patients with different types of pulmonary arterial hypertension. Poster presented at: European Society of Cardiology Annual Meeting; August 25-29, 2018; Munich, Germany. Poster P4538.","DOI":"10.1093\/eurheartj\/ehy563.P4538"},{"key":"10.1016\/j.chest.2020.08.2069_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.21693\/1933-088X-16.3.125","article-title":"Risk assessment in pulmonary arterial hypertension patients: the long and short of it","volume":"16","author":"Benza","year":"2018","journal-title":"Adv Pulm Hyperten"},{"issue":"142","key":"10.1016\/j.chest.2020.08.2069_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1183\/16000617.0077-2016","article-title":"Risk assessment in pulmonary arterial hypertension","volume":"25","author":"Raina","year":"2016","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.chest.2020.08.2069_bib14","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s12325-019-01030-4","article-title":"Assessment of risk of disease progression in pulmonary arterial hypertension: insights from an international survey of clinical practice","volume":"36","author":"Simons","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.chest.2020.08.2069_bib15","unstructured":"Wilson M, Keeley J, Kingman M, Rogers F. Risk assessment tools in pulmonary arterial hypertension (PAH): a survey of real-world practices and barriers to use. Paper presented at: PAH PHPN Symposium; September 5-7, 2019; Washington, DC. Abstract 1001."},{"issue":"1","key":"10.1016\/j.chest.2020.08.2069_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.chest.2019.08.2203","article-title":"Retrospective validation of the REVEAL 2.0 risk score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort","volume":"157","author":"Anderson","year":"2020","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2020.08.2069_bib17","doi-asserted-by":"crossref","first-page":"2000008","DOI":"10.1183\/13993003.00008-2020","article-title":"Risk stratification in pulmonary arterial hypertension using Bayesian analysis","volume":"56","author":"Kanwar","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2020.08.2069_bib18","doi-asserted-by":"crossref","unstructured":"Benza RL, Kanwar M, Raina A, et\u00a0al. Comparison of risk discrimination between the REVEAL 2.0 calculators, the French Pulmonary Registry algorithm, and the Bologna Method in patients with pulmonary arterial hypertension. Poster presented at: American Thoracic Society International Conference; May 17-22, 2019; Dallas, TX. Poster 11945.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A2512"},{"key":"10.1016\/j.chest.2020.08.2069_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2020.08.2069_bib20","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2020.08.2069_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/rccm.201908-1640OC","article-title":"Combination therapy with oral treprostinil for pulmonary arterial hypertension: a double-blind placebo-controlled clinical trial","volume":"201","author":"White","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2020.08.2069_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2020.08.2069_bib23","doi-asserted-by":"crossref","unstructured":"Sitbon O, Nikkho S, Benza RL, et\u00a0al. Novel composite clinical endpoints and risk scores used in clinical trials in PAH. Pulm Circ. 2020;2045894020962960.","DOI":"10.1177\/2045894020962960"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220342963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220342963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:01:19Z","timestamp":1762124479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220342963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0012369220342963"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.08.2069","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.08.2069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}